Dominik Schmiedel

Leipzig, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective.

Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective.

Journal: Human gene therapy

Published: August 03, 2026

Divergent on-target off-tumor effects by CAR T and CAR NK cells suggest different efficacy and safety of cell therapies.

Divergent on-target off-tumor effects by CAR T and CAR NK cells suggest different efficacy and safety of cell therapies.

Journal: Oncoimmunology

Published: September 05, 2025

Preclinical evaluation of a novel CD4 specific CAR NK cell therapy for T-cell malignancies.

Preclinical evaluation of a novel CD4 specific CAR NK cell therapy for T-cell malignancies.

Journal: Cytotherapy

Published: September 02, 2025

HO-1197 as a Multifaceted Therapeutic: Targeting the Cell Cycle, Angiogenesis, Metastasis, and Tumor Immunity in Hepatocellular Carcinoma.

HO-1197 as a Multifaceted Therapeutic: Targeting the Cell Cycle, Angiogenesis, Metastasis, and Tumor Immunity in Hepatocellular Carcinoma.

Journal: International journal of molecular sciences

Published: August 20, 2025

Enhanced solid tumor cell targeting by a neoepitope-encoding oncolytic measles virus combined with CAR therapy.

Enhanced solid tumor cell targeting by a neoepitope-encoding oncolytic measles virus combined with CAR therapy.

Journal: Molecular therapy. Oncology

Published: January 27, 2025

Evaluation of Anti-CAR Linker mAbs for CAR T Monitoring after BiTEs/bsAbs and CAR T-Cell Pretreatment.

Evaluation of Anti-CAR Linker mAbs for CAR T Monitoring after BiTEs/bsAbs and CAR T-Cell Pretreatment.

Journal: Biomedicines

Published: June 30, 2024

Linker-specific monoclonal antibodies present a simple and reliable detection method for scFv-based CAR NK cells.

Linker-specific monoclonal antibodies present a simple and reliable detection method for scFv-based CAR NK cells.

Journal: Molecular therapy. Methods & clinical development

Published: April 05, 2024

Empowering Natural Killer Cells to Combat Acute Myeloid Leukemia: Perspective on CAR-NK Cell Therapy.

Empowering Natural Killer Cells to Combat Acute Myeloid Leukemia: Perspective on CAR-NK Cell Therapy.

Journal: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Published: April 04, 2024

SMARCA5-mediated chromatin remodeling is required for germinal center formation.

SMARCA5-mediated chromatin remodeling is required for germinal center formation.

Journal: The Journal of experimental medicine

Published: March 08, 2024

Development of KoRV-pseudotyped lentiviral vectors for efficient gene transfer into freshly isolated immune cells.

Development of KoRV-pseudotyped lentiviral vectors for efficient gene transfer into freshly isolated immune cells.

Journal: Gene therapy

Published: October 11, 2023

CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma.

CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma.

Journal: Frontiers in immunology

Published: September 07, 2023

Optimized peptide nanofibrils as efficient transduction enhancers for in vitro and ex vivo gene transfer.

Optimized peptide nanofibrils as efficient transduction enhancers for in vitro and ex vivo gene transfer.

Journal: Frontiers in immunology

Published: July 31, 2023

Showing 1-12 of 35

Last Updated: 09/26/2026